Open menu Close Previous Next Facebook X LinkedIn YouTube WhatsApp Phone Newsletter Email Location AMSlab AMSvet AMSfood AMSbiopharma CIFGA Nexotech EU

Oncogalfarma

Innovación en biotecnología

New supplementary therapies for the treatment of cancer-related diseases

GalChimia, Oncostellae and AMSLab take part in the research project Oncogalfarma, aiming at developing new supplementary therapies for the treatment of cancer-related diseases. Research is focused on the field of inhibitors of the protein-protein interaction (PPI) and nuclear receptors.

This project is funded by the Regional Government Xunta de Galicia and the ERDF in the framework of the Operational Programme ERDF Galicia 2007-2013 through the sub-programme CONECTA PEME.

Amount of the aid granted: EUR 114,745.76

FEDER
Xunta de Galicia
Axencia Galega de Innovación

Involved companies:

  • AMSlab